Tag: BURST-AF
Argá Medtech reports 94% lesion durability and “strong safety profile” with...
Argá Medtech has announced positive clinical results from the BURST-AF first-in-human trial, demonstrating the safety, effectiveness and durability of its Coherent sine-burst electroporation (CSE)...